Eidos Roundtable: Navigating Sustainable Business Models for Healthcare Startups

Saturday, May 8, 1:30 PM – 4:30 PMVCBeat China, the Harvard China Healthcare Club, and EY-Parthenon will jointly host a roundtable seminar titled “Eidos,” themed “How Healthcare Startups Can Break Through: Exploring Sustainable Business Models and Pathways.” The seminar will provide in-depth analysis and insights on how healthcare startups can address and overcome the challenges they face amid the wave of healthcare entrepreneurship, achieve market breakthroughs through iterative development, and gain strategic and tactical advantages.

The distinguished guests present boast global perspectives, outstanding practical industry experience, and a proven track record in entrepreneurship. Drawing on their dual insights as both professional managers and entrepreneurs, they will share expertise on topics such as product requirement research and validation, R&D cycles and procedures, core team building and management, application and filing for medical device licenses, and preparation for key commercialization stages along with corresponding risk mitigation strategies. We sincerely invite you to join us and gain exclusive, practical insights into the medical industry.

Scan the QR code below to register.

How should the core team structure be built at different stages of a medical startup’s development? What qualities and capabilities should managers of startups possess? What does an excellent entrepreneur look like in the eyes of investors? How should startup teams conduct recruitment and selection, design compensation packages, develop talent development plans, and establish incentive mechanisms?

How to Establish Partnerships with Hospitals and Efficiently Conduct Clinical Collaborations: Key Considerations

What are the key stages and critical timelines to manage during the preparation and application process for a medical device license?

For companies still in the early stages of research and development, how can they enhance their sensitivity to market demands and obtain timely market feedback? Furthermore, how can they effectively communicate actual market needs to the R&D team to foster cross-departmental collaboration?

How can product R&D be closely aligned with corporate strategy to build an effective product pipeline, while effectively penetrating the market through gaps left by large enterprises and achieving success?

How to Successfully Launch a Product to Market: What Preparations Are Essential for Success in the Commercialization Phase? What Are the Industry’s Best Practices?

How to Formulate Clear Strategies and Business Models During the Commercialization Phase? How to Effectively Drive and Execute Them to Achieve Rapid Expansion in Sales Revenue and Market Share?

How Can Innovative Products Shape the Market? How Can Startups Guide Market Development Like Large Enterprises?

The confirmed guests for this roundtable discussion are as follows (listed in alphabetical order by surname):

Ding Wei

Chairman & Founder of Pinfeng Medical

Chairman & Founder of PinFeng Medical, former President of Kehua Bio-Engineering, and former Asia-Pacific President & Global Vice President of bioMérieux, a global giant in in vitro diagnostics. Mr. Ding Wei has over 20 years of experience in investment, mergers and acquisitions, and management in the healthcare industry, particularly in the in vitro diagnostics sector. Mr. Ding completed his undergraduate studies at the School of Life Sciences, Fudan University, and holds an MBA from the University of Utah, USA.

Fu Xiaoyang

Prominent Angel Investor in the Healthcare Industry

Mr. Fu Xiaoyang, a renowned angel investor in the healthcare industry and the founder and former chairman of Jietong Medical (later acquired by Tigermed), boasts over 20 years of experience in the medical sector. He possesses extensive resources and expertise in clinical registration and regulatory affairs for medical devices, along with profound insights and a successful track record in investing in early-stage health-tech projects. The consulting firm he founded, Jietong Consulting, has become a well-known one-stop comprehensive service provider in China’s medical device industry, covering areas such as quality management systems, testing, and clinical regulatory registration. Over the past two decades, he has organized and implemented more than 800 clinical trials, successfully securing over 4,000 medical device registration certificates from the National Medical Products Administration (NMPA) for more than 3,000 medical device companies, 70% of which were for Class III high-risk and innovative medical device products.

Su Hua

EY-Parthenon Partner, Healthcare Industry

Managing Partner, Life Sciences and Healthcare Industry, EY-Parthenon. With 15 years of experience in strategic consulting, he specializes in the pharmaceutical and medical device industries. He has provided extensive services to numerous healthcare enterprises in areas such as business planning, financing, product launch and market access, and growth strategies, supporting companies from their startup phase through IPO and onward to further strategic development. Prior to joining EY-Parthenon, he held core positions at several internationally renowned consulting firms.

Dr. Dong Wu

Former Global Vice President of Medtronic

Former Global Vice President of Medtronic; Former General Manager, Greater China Region, Kanghui Business; Former Vice President, Medtronic Covidien China R&D Center. During his tenure at the Medtronic Covidien China R&D Center, Dr. Wu Dong led a team of 300 professional R&D personnel to gain in-depth insights into the Chinese healthcare market and patient needs. By integrating clinical experience, market demands, and technological innovation, he developed new products and technologies tailored to China’s specific conditions. Dr. Wu Dong holds a Ph.D. in Polymer Engineering and Science from the University of Massachusetts.

Dr. Xin Zhang

Head of Peijia Medical Innovation Incubator

Head of Peijia Medical Innovation Incubator; former Vice President and General Manager of Medical Devices at Shenzhen Salubris Pharmaceuticals; former Global Marketing Director for Endoscopy at Smith & Nephew; Senior R&D Scientist in Cardiac Rhythm and Disease Management at Medtronic’s Minnesota headquarters. Dr. Zhang Xin brings 20 years of professional experience spanning end-to-end R&D to commercialization, as well as investment and mergers and acquisitions. During his tenure at Salubris, Dr. Zhang spearheaded over RMB 1 billion in M&A investments and post-merger integration for the company’s medical device division. He successfully transformed the department, initially focused on early-stage R&D, into a comprehensive business unit integrating R&D, clinical affairs, manufacturing, marketing, and sales, achieving annual sales exceeding RMB 80 million in 2019. Dr. Zhang holds a Ph.D. in Biomedical Engineering from the University of Minnesota and an MBA from the Wharton School of the University of Pennsylvania.

Zhang Yi

Managing Partner, Huagai Capital Medical Yangtze River Delta Fund

Mr. Zhang Yi, Managing Partner of Huagai Capital’s Yangtze River Delta Healthcare Fund and former Founding Partner of Sinopharm Capital, also serves as a Director of the “China Healthcare Investment 50 Forum.” With 20 years of experience in the healthcare sector, Mr. Zhang has led or participated in landmark investments including Kangdelai, Jiyao Holdings, LBP Medicine, Allist Biopharma, InnoCare Pharma, and ImmuneOnco Biopharma. He holds a Master’s degree in Clinical Medicine from Fudan University.

Eidos is a series of sharing events launched by Walden China for entrepreneurs in the healthcare industry. We aim to help, disseminate knowledge to, and empower more healthcare entrepreneurs by building this platform. Eidos is a Greek term that translates to “Idea” or “Form,” a core concept in Platonic philosophy. Plato used Eidos to refer to the core and essence underlying all things in the world, transcending the ever-changing world of appearances. We use this term as a metaphor for the timeless commonalities behind entrepreneurial success. Meanwhile, the Platonic Academy, founded by Plato in 385 BC, served as the prototype for all modern universities. There, students sat on the ground, engaging in philosophical discourse with their teacher—a setting that aligns well with the communicative, inspirational, and interactive nature of our sharing events.

Hodes provides tailored, one-stop recruitment consulting services to clients and candidates. With branches in Shanghai, Suzhou, and Shenzhen, we deliver end-to-end professional recruitment solutions at local, national (China), and global levels.

Waters China stood out with its excellent human resources management mechanism, the power of teamwork, and high employee recognition, winning the “2019 Best Companies to Work for in Asia” award presented by HR Asia, an influential authoritative media publication on human resources in Asia.